Etiology of Persistent Microalbuminuria in Nigeria
Posted in
The Vanderbilt Institute for Global Health (VIGH) and Aminu Kano Teaching Hospital (AKTH) in Kano, Nigeria have received a federal grant to study the factors associated with microalbuminuria among participants in an ongoing clinical trial of genetically at-risk HIV-positive adult Nigerians.
The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) grant will provide $2.2 million over the next four years.
Optimal Management of HIV Infected Adults at Risk for Kidney Disease in Nigeria
Posted in
Principal Investigator(s):
Muktar Aliyu, M.D., M.P.H., Dr.P.H.
William Wester, M.D., M.P.H.
Vanderbilt-Nigeria Research Administration and Management Training Program (V-RAMP)
Posted in
About V-RAMP
Vanderbilt-Nigeria Building Research Capacity in HIV/Non-communicable Diseases (V-BRCH)
Posted in
https://vumc.org/v-brch
The Vanderbilt-Nigeria Building Research Capacity in HIV/Non-communicable Diseases (V-BRCH) Program builds capacity of Nigerian investigators to successfully initiate and implement high-quality clinical trials in HIV-associated non-communicable diseases.
Avante: Towards Epidemic Control
Posted in
https://www.vumc.org/friends-in-global-health/avante
Principal Investigator(s):
William Wester, M.D., M.P.H.